ETFs Analysis & Opinion

Investing in passive-income stocks appeal to many investors who are nervous about the downward-trending market. In the first four months of the year, broader indices as well many darlings of the...

Despite Wall Street’s ongoing bearish sentiment, new exchange-traded funds (ETF) have continued to reach the market in impressive numbers in 2022. ETFs listed in the US currently have more than...

Natural gas has been one of the best-performing commodities of the year. Tailwinds have come from the war in Ukraine, cold weather in the US, and decreasing inventory levels of the energy commodity....

Increasing awareness about global warming and sky-high energy prices have sparked renewed interest in clean technology (cleantech) stocks. Experts believe we might be witnessing a long-term structural...

Broader markets have been volatile since the start of 2022. The first quarter of the year— as well as the month of April thus far—has been brutal for many high-growth tech companies, aka...

AT&T (NYSE:T) recently completed the much-awaited WarnerMedia spin-off. The media group officially merged with Discovery, creating a new entity, Warner Bros Discovery (NASDAQ:WBD), which started...

Banks and other financial names have reclaimed Wall Street’s spotlight this earnings season amid the perspective of rising interest rates. Moves in those shares naturally affect the prices of...

For many investors, dividend-paying stocks are an attractive option to generate a safe, passive income stream regardless of market conditions. However, as macroeconomic uncertainties upend global...

Record inflation levels, rising interest rates, and current geopolitical worries represent a big question mark for many sectors of the economy. Knowing that Wall Street does not like uncertainty,...

As the busy Q2 earnings season starts, many investors are looking for opportunities in exchange-traded funds (ETFs) to diversify their portfolios and take advantage of the market’s leading...

Biotechnology stocks represent companies that research, develop or market healthcare-related therapies or products. They typically use living organisms, biological systems, or derivatives. With a...

As the economic and geopolitical landscape shifts, investors have been reevaluating their portfolios. Metrics suggest that we have moved away from a bull market in many asset classes, especially...

The Bill & Melinda Gates Foundation is among the largest private philanthropic foundations worldwide. Established in 2000, it defines its primary objective as to: “Help all people lead...

After an incredible bull run at the beginning of the year, oil prices have recently declined. As we write, Brent oil is at $103, while US West Texas Intermediate, WTI, is trading below the...